Stock BHVN BIOHAVEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Biohaven Ltd.

Equities

BHVN

VGG1110E1079

Real-time Estimate Cboe BZX
Other stock markets
 11:28:22 2024-06-04 am EDT 		5-day change 1st Jan Change
33.85 USD -3.56% Intraday chart for Biohaven Ltd. -4.41% -17.99%
May. 29 Biohaven Ltd. Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas Including Immunology, Neuroscience, Metabolic Disorders and Oncology At Annual Investor R&D Day CI
May. 29 Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOHAVEN LTD.
Other Biotechnology & Medical Research
-0.37%-4.41%-17.99%+61.60% - 3.05B
Bearish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. BHVN Stock
  4. Charts Biohaven Ltd.
  5. Comparison Chart